Cell therapy using induced pluripotent stem cells or somatic stem cells: This is the question

Current Stem Cell Research and Therapy

Volumn 7, Issue 3, 2012, Pages 191-196

  Somoza, Rodrigo A ^a   Rubio, Francisco J ^b  

^a DEPARTAMENTO DE FÍSICA   (Chile)

^b UNIVERSIDAD DE LOS ANDES   (Chile)

Author keywords

Cell plasticity; Epigenetic induction; Induced pluripotent stem cells; Mesenchymal stem cells; Reprogramming; Somatic stem cells

Indexed keywords

KRUPPEL LIKE FACTOR 4; OCTAMER TRANSCRIPTION FACTOR 4; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR SOX2;

ADIPOSE TISSUE; AMNION; BONE MARROW; CELL FATE; CELL LINEAGE; CELL PROLIFERATION; CELL TRANSFER; DNA MODIFICATION; EMBRYONIC STEM CELL; ENDOMETRIUM; EPIGENETICS; FETUS BLOOD; GENE OVEREXPRESSION; GINGIVA; HOMEOSTASIS; HUMAN; IMMUNITY; IMMUNOREGULATION; LUNG; NONHUMAN; NUCLEAR REPROGRAMMING; ONCOGENE C MYC; ORGANOGENESIS; PANCREAS; PLACENTA; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SOMATIC CELL; SOMATIC STEM CELL; STEM CELL TRANSPLANTATION; SYNOVIAL FLUID; TOOTH PULP; UMBILICAL CORD BLOOD;

ADULT; ADULT STEM CELLS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; HUMANS; INDUCED PLURIPOTENT STEM CELLS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; PROTO-ONCOGENE PROTEINS C-MYC; SOXB1 TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC;

EID: 84860276298     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488812799859865     Document Type: Review

References (84)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stemcell lines derived from human blastocysts. Science 1998; 282:1145-7.
2. National Institutes of Health (NIH). Stem Cell Information: HumanEmbryonic Stem Cell Policy Under Former President Bush (Aug. 9, 2001-Mar. 9, 2009). http://stemcells.nih.gov/policy/-2001policy.htm (Accessed May 12, 2011).
3. Ho R, Chronis C, Plath K. Mechanistic insights into reprogrammingto induced pluripotency. J Cell Physiol 2011; 226: 868-78.
4. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotentstem cells from adult human fibroblasts by defined factors. Cell2007; 131: 861-72.
5. Takahashi K, Yamanaka S. Induction of pluripotent stem cells frommouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-76.
6. Cox J L, Rizzino A. Induced pluripotent stem cells: what lies beyondthe paradigm shift. Exp Biol Med 2010; 235: 148-58.
7. Kim JB, Greber B, Arauzo-Bravo MJ, et al. Direct reprogrammingof human neural stem cells by OCT4. Nature 2009; 461: 649-3.
8. Eggenschwiler R, Cantz T. Induced pluripotent stem cells generatedwithout viral integration. Hepatology 2009; 49: 1048-9.
9. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viralvectors. Science 2008; 322: 949-53.
10. Woltjen K, Michael IP, Mohseni P, et al. piggyBac transpositionreprograms fibroblasts to induced pluripotent stem cells. Nature2009; 458: 766-70.
11. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogrammingfactors. Nature 2009; 458: 771-5.
12. Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell 2004;116: 639-48.
13. Bieback K, Kluter H. Mesenchymal stromal cells from umbilicalcord blood. Curr Stem Cell Res Ther 2007; 2: 310-23.
14. Pittenger MF. Mesenchymal stem cells from adult bone marrow. Methods Mol Biol 2008; 449: 27-44.
15. Alison MR, Islam S. Attributes of adult stem cells. J Pathol 2009;217: 144-60.
16. Barker N, Bartfeld S, Clevers H. Tissue-resident adult stem cellpopulations of rapidly self-renewing organs. Cell Stem Cell 2010;7: 656-70.
17. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymalstem cells reside in virtually all post-natal organs and tissues. J CellSci 2006; 119: 2204-13.
18. Friedenstein A J, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopicof bone marrow. Analysis of precursor cells for osteogenicand hematopoietic tissues. Transplantation 1968; 6: 230-47.
19. Wagner W, Ho AD. Mesenchymal stem cell preparations--comparing apples and oranges. Stem Cell Rev 2007; 3: 239-48.
20. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria fordefining multipotent mesenchymal stromal cells. The InternationalSociety for Cellular Therapy position statement. Cytotherapy 2006;8: 315-7.
21. Caplan AI. Adult mesenchymal stem cells for tissue engineeringversus regenerative medicine. J Cell Physiol 2007; 213: 341-7.
22. Krause DS. Plasticity of marrow-derived stem cells. Gene Ther2002; 9: 754-8.
23. Abuljadayel IS. Harnessing pluripotency from differentiated cells:a regenerative source for tissue-specific stem cell therapies. CurrStem Cell Res Ther 2006; 1: 325-31.
24. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymalstem cells derived from adult marrow. Nature 2002; 418:41-9.
25. Jackson L, Jones DR, Scotting P, Sottile V. Adult mesenchymalstem cells: differentiation potential and therapeutic applications. JPostgrad Med 2007; 53: 121-7.
26. Phinney DG, Prockop DJ. Concise review: mesenchymalstem/multipotent stromal cells: the state of transdifferentiation andmodes of tissue repair--current views. Stem Cells 2007; 25: 2896-902.
27. Hermann A, Gastl R, Liebau S, et al. Efficient generation of neuralstem cell-like cells from adult human bone marrow stromal cells. JCell Sci 2004; 117: 4411-22.
28. Long X, Olszewski M, Huang W, Kletzel M. Neural cell differentiationin vitro from adult human bone marrow mesenchymal stemcells. Stem Cells Dev 2005; 14: 65-9.
29. Somoza R, Juri C, Baes M, Wyneken U, Rubio FJ. Intranigraltransplantation of epigenetically induced BDNF-secreting humanmesenchymal stem cells: implications for cell-based therapies inParkinson's disease. Biol Blood Marrow Transplant 2010; 16:1530-40.
30. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, et al. Adult bonemarrow stromal cells differentiate into neural cells in vitro. ExpNeurol 2000; 164: 247-56.
31. Somoza R, Conget P, Rubio FJ. Neuropotency of human mesenchymalstem cell cultures: clonal studies reveal the contribution ofcell plasticity and cell contamination. Biol Blood Marrow Transplant2008; 14: 546-55.
32. Chua SJ, Casper RF, Rogers IM. Toward Transgene-Free InducedPluripotent Stem Cells: Lessons from Transdifferentiation Studies. Cell Reprogram 2011; 13: 273-80.
33. Jopling C, Boue S, Izpisua Belmonte JC. Dedifferentiation, transdifferentiationand reprogramming: three routes to regeneration. Nat Rev Mol Cell Biol 2011; 12: 79-9.
34. De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP. Multipotentmesenchymal stem cells from adult human synovial membrane. ArthritisRheum 2001; 44: 1928-42.
35. Huang GT, Gronthos S, Shi S. Mesenchymal stem cells derivedfrom dental tissues vs. those from other sources: their biology androle in regenerative medicine. J Dent Res 2009; 88: 792-806.
36. In't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Isolationof mesenchymal stem cells of fetal or maternal origin fromhuman placenta. Stem Cells 2004; 22: 1338-45.
37. Ishkitiev N, Yaegaki K, Calenic B, et al. Deciduous and permanentdental pulp mesenchymal cells acquire hepatic morphologic andfunctional features in vitro. J Endod 2010; 36: 469-74.
38. Kassis I, Zangi L, Rivkin R, et al. Isolation of mesenchymal stemcells from G-CSF-mobilized human peripheral blood using fibrinmicrobeads. Bone Marrow Transplant 2006; 37: 967-76.
39. Krause DS, Theise ND, Collector MI, et al. Multi-organ, multilineageengraftment by a single bone marrow-derived stem cell. Cell 2001; 105: 369-77.
40. Lecourt S, Marolleau JP, Fromigue O, et al. Characterization ofdistinct mesenchymal-like cell populations from human skeletalmuscle in situ and in vitro. Exp Cell Res 2010; 316: 2513-26.
41. Mitrano TI, Grob MS, Carrion F, et al. Culture and characterizationof mesenchymal stem cells from human gingival tissue. J Periodontol2010; 81: 917-25.
42. Musina RA, Bekchanova ES, Belyavskii AV, Sukhikh GT. Differentiationpotential of mesenchymal stem cells of different origin. Bull Exp Biol Med 2006; 141: 147-51.
43. Riekstina U, Muceniece R, Cakstina I, Muiznieks I, Ancans J. Characterization of human skin-derived mesenchymal stem cellproliferation rate in different growth conditions. Cytotechnology2008; 58: 153-62.
44. Rojewski MT, Weber BM, Schrezenmeier H. Phenotypic Characterizationof Mesenchymal Stem Cells from Various Tissues. Transfus Med Hemother 2008; 35: 168-84.
45. Xu J, Wang W, Kapila Y, Lotz J, Kapila S. Multiple differentiationcapacity of STRO-1+/CD146+ PDL mesenchymal progenitor cells. Stem Cells Dev 2009; 18: 487-96.
46. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a sourceof multipotent stem cells. Mol Biol Cell 2002; 13: 4279-95.
47. Crisan M, Yap S, Casteilla L, et al. A perivascular origin for mesenchymalstem cells in multiple human organs. Cell Stem Cell2008; 3: 301-13.
48. da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivoidentity of mesenchymal stem cells. Stem Cells 2008; 26: 2287-99.
49. Crisan M, Chen CW, Corselli M, Andriolo G, Lazzari L, Peault B. Perivascular multipotent progenitor cells in human organs. Ann NY Acad Sci 2009; 1176: 118-23.
50. Cai X, Lin Y, Hauschka P, Grottkau BE. Adipose Stem CellsOriginate from Perivascular Cells. Biol Cell 2011; 103: 435-47.
51. Lee RH, Kim B, Choi I, et al. Characterization and expressionanalysis of mesenchymal stem cells from human bone marrow andadipose tissue. Cell Physiol Biochem 2004; 14: 311-24.
52. Salgado AJ, Reis RL, Sousa NJ, Gimble JM. Adipose tissue derivedstem cells secretome: soluble factors and their roles in regenerativemedicine. Curr Stem Cell Res Ther 2010; 5: 103-10.
53. Sloan AJ, Waddington RJ. Dental pulp stem cells: what, where, how? Int J Paediatr Dent 2009; 19: 61-70.
54. Arora V, Arora P, Munshi AK. Banking stem cells from humanexfoliated deciduous teeth (SHED): saving for the future. J ClinPediatr Dent 2009; 33: 289-94.
55. Jo YY, Lee HJ, Kook SY, et al. Isolation and characterization ofpostnatal stem cells from human dental tissues. Tissue Eng 2007;13: 767-73.
56. Perry BC, Zhou D, Wu X, et al. Collection, cryopreservation, andcharacterization of human dental pulp-derived mesenchymal stemcells for banking and clinical use. Tissue Eng Part C Methods2008; 14: 149-56.
57. Shi S, Gronthos S. Perivascular niche of postnatal mesenchymalstem cells in human bone marrow and dental pulp. J Bone MinerRes 2003; 18: 696-704.
58. Caplan AI. All MSCs are pericytes? Cell Stem Cell 2008; 3: 229-30.
59. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006; 98: 1076-84.
60. Carvalho MM, Teixeira FG, Reis RL, Sousa N, Salgado AJ. Mesenchymalstem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerativemedicine. Curr Stem Cell Res Ther 2011; 6: 221-8.
61. Kassis I, Vaknin-Dembinsky A, Karussis D. Bone marrow mesenchymalstem cells: agents of immunomodulation and neuroprotection. Curr Stem Cell Res Ther 2010; 6: 63-8.
62. Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severeacute graft-versus-host disease with third party haploidentical mesenchymalstem cells. Lancet 2004; 363: 1439-41.
63. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O. HLA expression and immunologic properties of differentiated andundifferentiated mesenchymal stem cells. Exp Hematol 2003; 31:890-6.
64. Caplan AI. Why are MSCs therapeutic? New data: new insight. JPathol 2009; 217: 318-24.
65. Krasnodembskaya A, Song Y, Fang X, et al. Antibacterial effect ofhuman mesenchymal stem cells is mediated in part from secretionof the antimicrobial peptide LL-37. Stem Cells 2010; 28: 2229-38.
66. Barzilay R, Melamed E, Offen D. Introducing transcription factorsto multipotent mesenchymal stem cells: making transdifferentiationpossible. Stem Cells 2009; 27: 2509-15.
67. Masip M, Veiga A, Izpisua Belmonte JC, Simon C. Reprogrammingwith defined factors: from induced pluripotency to inducedtransdifferentiation. Mol Hum Reprod 2010; 16: 856-68.
68. Song L, Tuan RS. Transdifferentiation potential of human mesenchymalstem cells derived from bone marrow. FASEB J 2004; 18:980-2.
69. Hanna JH, Saha K, Jaenisch R. Pluripotency and cellular reprogramming:facts, hypotheses, unresolved issues. Cell 2010; 143:508-25.
70. Hochedlinger K, Plath K. Epigenetic reprogramming and inducedpluripotency. Development 2009; 136: 509-23.
71. Zhou H, Wu S, Joo JY, et al. Generation of induced pluripotentstem cells using recombinant proteins. Cell Stem Cell 2009; 4: 381-4.
72. Shi Y, Desponts C, Do JT, Hahm HS, Scholer HR, Ding S. Inductionof pluripotent stem cells from mouse embryonic fibroblasts byOct4 and Klf4 with small-molecule compounds. Cell Stem Cell2008; 3: 568-74.
73. Shi Y, Do JT, Desponts C, Hahm HS, Scholer HR, Ding S. A combinedchemical and genetic approach for the generation of inducedpluripotent stem cells. Cell Stem Cell 2008; 2: 525-8.
74. Aasen T, Raya A, Barrero MJ, et al. Efficient and rapid generationof induced pluripotent stem cells from human keratinocytes. NatBiotechnol 2008; 26: 1276-84.
75. Giorgetti A, Montserrat N, Aasen T, et al. Generation of inducedpluripotent stem cells from human cord blood using OCT4 andSOX2. Cell Stem Cell 2009; 5: 353-7.
76. Kunisato A, Wakatsuki M, Kodama Y, Shinba H, Ishida I, NagaoK. Generation of induced pluripotent stem cells by efficient reprogrammingof adult bone marrow cells. Stem Cells Dev 2010; 19:229-38.
77. Yan X, Qin H, Qu C, Tuan RS, Shi S, Huang GT. iPS cells reprogrammedfrom human mesenchymal-like stem/progenitor cells ofdental tissue origin. Stem Cells Dev 2010; 19: 469-80.
78. Ma T. Mesenchymal stem cells: From bench to bedside. World JStem Cells 2010; 26: 13-7.
79. Tolar J, Le Blanc K, Keating A, Blazar BR. Concise review: hittingthe right spot with mesenchymal stromal cells. Stem Cells 2010;28: 1446-55.
80. Hanson SE, Bentz ML, Hematti P. Mesenchymal stem cell therapyfor nonhealing cutaneous wounds. Plast Reconstr Surg 2010; 125:510-6.
81. Lin G, Xu, RH. Progresses and challenges in optimization of humanpluripotent stem cell culture. Curr Stem Cell Res Ther 2010;5: 207-14.
82. Zhao T, Zhang ZN, Rong Z, Xu Y. Immunogenicity of inducedpluripotent stem cells. Nature 2011; 474: 212-5.
83. Bjornson CR, Rietze RL, Reynolds BA, Magli MC, Vescovi AL. Turning brain into blood: a hematopoietic fate adopted by adultneural stem cells in vivo. Science 1999; 283: 534-7.
84. Park IH, Arora N, Huo H, et al. Disease-specific induced pluripotentstem cells. Cell 2008; 134: 877-86.